Temporal alterations in concentrations of sera cytokines/chemokines in sepsis due to group B streptococcus infection in a neonate

Japanese Journal of Infectious Diseases

Volumn 61, Issue 5, 2008, Pages 382-385

  Okazaki, Kaoru ^a   Kondo, Masatoshi ^a   Kato, Masahiko ^b   Nishida, Akira ^a   Takahashi, Hidehiro ^a   Noda, Masahiro ^c   Kimura, Hirokazu ^c  

^a Tokyo Metropolitan Hachioji Children's Hospital   (Japan)

^b GUNMA PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; C REACTIVE PROTEIN; CEFTRIAXONE; CHEMOKINE; CLINDAMYCIN; CYTOKINE; ERYTHROMYCIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PENICILLIN G; TUMOR NECROSIS FACTOR ALPHA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BLOOD ANALYSIS; CASE REPORT; CESAREAN SECTION; CHILDBIRTH; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNE RESPONSE; INFANT; MINIMUM INHIBITORY CONCENTRATION; NEWBORN SEPSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE FETUS MEMBRANE RUPTURE; RESPIRATORY TRACT INTUBATION; SKIN EXAMINATION; SPUTUM ANALYSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; LOW BIRTH WEIGHT; MICROBIOLOGY; NEWBORN; SEPSIS; UPREGULATION;

CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; UP-REGULATION;

EID: 54449097911     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Doran, K.S. and Nizet, V. (2004): Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol. Microbiol., 54, 23-31.
2. Schrag, S.J., Zywicki, S., Farley, M.M., et al. (2000): Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med., 342, 15-20.
3. Hodge, G., Hodge, S., Haslam, R., et al. (2004): Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes-association with neonatal sepsis. Clin. Exp. Immunol., 137, 402-407.
4. Berner, R., Niemeyer, C.M., Leititis, J.U., et al. (1998): Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr. Res., 44, 469-477.
5. Centers for Disease Control and Prevention (2002): Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. Morbid. Mortal. Wkly. Rep., 51 (RR-11), 1-22.
6. Okazaki, K., Kondo, M., Kato, M., et al. (2008): Serum cytokines/ chemokines profiles in neonates with meconium aspiration syndrome. Pediatrics, 121, e748-753.
7. Henneke, P. and Berner, R. (2006): SIRS and group B streptococcal sepsis in newborns: pathogenesis and perspectives in adjunctive therapy. Semin. Fetal. Neonatal. Med., 11, 333-342.
8. Henneke, P., Takeuchi, O., Malley, R., et al. (2002): Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J. Immunol., 169, 3970-3977.
9. Miura, E., Procianoy, R.S., Bittar, C., et al. (2002): A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics, 30-35.
10. Cusumano, V., Genovese, F., Mancuso, G., et al. (1996): Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect. Immun., 64, 2850-2852.
11. Vella, A.T., Dow, S., Potter, T.A., et al. (1998): Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 95, 3810-3815.
12. Yamashiro, S., Kamohara, H. and Yoshimura, T. (1999): MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression. J. Leukoc. Biol., 65, 671-679.
13. Gu, L., Tseng, S., Horner, R.M., et al. (2000): Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature, 404, 407-411.
14. Sin, J.I., Kim, J., Pachuk, C., et al. (2000): Protective immune correlates can segregate by vaccine type in a murine herpes model system. Clin. Diagn. Lab. Immunol., 7, 751-758.